HSPA9 and hepatocellular carcinoma: Collectively, these results indicated that CaA inhibited the activity of mortalin by both transcriptional (indirectly, via blocking NF-κB) and posttranscriptional (directly, via targeting and inducing the ubiquitin-mediated degradation of mortalin) modifications in HCC cells.